Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 |
|---|---|---|---|---|---|---|
| 1 | NAMILUMAB | 1件: Namilumab Namilumab (Namilumab) | - | - | - | 2件: 46 46, 84 💬
|
| 2 | Namilumab (MT203) | 1件: Namilumab Namilumab (Namilumab) | - | - | - | 1件: 46 46 💬
|
| 3 | NamilumabProduct Code: KIN-1902Pharmaceutical Form: Solution for injectionINN or Proposed INN: NAMILUMABCAS Number: 1206681-39-1Current Sponsor code: KIN-1902 (previously IZN-101, MT203, AMG203)Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 150-Pharmaceutical form of the placebo: Solution for injectionRoute of administration of the placebo: Subcutaneous use | - | - | - | - | 1件: 84 84 💬
|
| 4 | Open label Namilumab | 1件: Namilumab Namilumab (Namilumab) | - | - | - | 1件: 84 84 💬
|